Crossmark

ESCP best practice: development of the national methodology for the provision of clinical-pharmaceutical care and its implementation in the healthcare system of the Czech Republic

Crossref DOI link: https://doi.org/10.1007/s11096-025-02009-8

Published Online: 2025-09-30

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hartinger, Jan Miroslav

Tašková, Ivana

Gregorová, Jana

Slanař, Ondřej

Fialová, Daniela
License Information

Text and Data Mining valid from 2025-09-30

Version of Record valid from 2025-09-30
More Information

Article History

Received: 30 June 2025

Accepted: 26 August 2025

First Online: 30 September 2025

Declarations

:

: JH and JG are members of the general committee of Czech Professional Society of Clinical Pharmacy and therefore were involved in national CP policy. DF is a chair of the “Ageing, Polypharmacy and Changes in the Therapeutic Value of Drugs in the AgeD” Research Unit and was a leader for the Czech research team of projects stated in Table 5. The authors state that they have no other competing interests regarding this article.

: Not required.

Document is current

Any future updates will be listed below